SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document

Online resources and useful tools - a compass in the land of biomarker discovery

Davide Bedognetti, James M. Balwit, Ena Wang, Mary L. Disis, Cedrik M. Britten, Lucia G. Delogu, Sara Tomei, Bernard A. Fox, Thomas F. Gajewski, Francesco M. Marincola, Lisa H. Butterfield

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are durable, dramatically extending survival. Extensive research efforts are being made to identify and validate biomarkers that can help identify subsets of cancer patients that will benefit most from these novel immunotherapies. In addition to the clear advantage of such predictive biomarkers, immune biomarkers are playing an important role in the development, clinical evaluation and monitoring of cancer immunotherapies. This Cancer Immunotherapy Resource Document, prepared by the Society for Immunotherapy of Cancer (SITC, formerly the International Society for Biological Therapy of Cancer, iSBTc), provides key references and online resources relevant to the discovery, evaluation and clinical application of immune biomarkers. These key resources were identified by experts in the field who are actively pursuing research in biomarker identification and validation. This organized collection of the most useful references, online resources and tools serves as a compass to guide discovery of biomarkers essential to advancing novel cancer immunotherapies.

Original languageEnglish
Article number155
JournalJournal of Translational Medicine
Volume9
Issue number1
DOIs
Publication statusPublished - 19 Sep 2011
Externally publishedYes

Fingerprint

Biological Therapy
Biomarkers
Tumor Biomarkers
Immunotherapy
Neoplasms
Research
Monitoring
Survival

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document : Online resources and useful tools - a compass in the land of biomarker discovery. / Bedognetti, Davide; Balwit, James M.; Wang, Ena; Disis, Mary L.; Britten, Cedrik M.; Delogu, Lucia G.; Tomei, Sara; Fox, Bernard A.; Gajewski, Thomas F.; Marincola, Francesco M.; Butterfield, Lisa H.

In: Journal of Translational Medicine, Vol. 9, No. 1, 155, 19.09.2011.

Research output: Contribution to journalReview article

Bedognetti, Davide ; Balwit, James M. ; Wang, Ena ; Disis, Mary L. ; Britten, Cedrik M. ; Delogu, Lucia G. ; Tomei, Sara ; Fox, Bernard A. ; Gajewski, Thomas F. ; Marincola, Francesco M. ; Butterfield, Lisa H. / SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document : Online resources and useful tools - a compass in the land of biomarker discovery. In: Journal of Translational Medicine. 2011 ; Vol. 9, No. 1.
@article{48c56b791e284e40b04e74e5f6826bd8,
title = "SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery",
abstract = "Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are durable, dramatically extending survival. Extensive research efforts are being made to identify and validate biomarkers that can help identify subsets of cancer patients that will benefit most from these novel immunotherapies. In addition to the clear advantage of such predictive biomarkers, immune biomarkers are playing an important role in the development, clinical evaluation and monitoring of cancer immunotherapies. This Cancer Immunotherapy Resource Document, prepared by the Society for Immunotherapy of Cancer (SITC, formerly the International Society for Biological Therapy of Cancer, iSBTc), provides key references and online resources relevant to the discovery, evaluation and clinical application of immune biomarkers. These key resources were identified by experts in the field who are actively pursuing research in biomarker identification and validation. This organized collection of the most useful references, online resources and tools serves as a compass to guide discovery of biomarkers essential to advancing novel cancer immunotherapies.",
author = "Davide Bedognetti and Balwit, {James M.} and Ena Wang and Disis, {Mary L.} and Britten, {Cedrik M.} and Delogu, {Lucia G.} and Sara Tomei and Fox, {Bernard A.} and Gajewski, {Thomas F.} and Marincola, {Francesco M.} and Butterfield, {Lisa H.}",
year = "2011",
month = "9",
day = "19",
doi = "10.1186/1479-5876-9-155",
language = "English",
volume = "9",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document

T2 - Online resources and useful tools - a compass in the land of biomarker discovery

AU - Bedognetti, Davide

AU - Balwit, James M.

AU - Wang, Ena

AU - Disis, Mary L.

AU - Britten, Cedrik M.

AU - Delogu, Lucia G.

AU - Tomei, Sara

AU - Fox, Bernard A.

AU - Gajewski, Thomas F.

AU - Marincola, Francesco M.

AU - Butterfield, Lisa H.

PY - 2011/9/19

Y1 - 2011/9/19

N2 - Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are durable, dramatically extending survival. Extensive research efforts are being made to identify and validate biomarkers that can help identify subsets of cancer patients that will benefit most from these novel immunotherapies. In addition to the clear advantage of such predictive biomarkers, immune biomarkers are playing an important role in the development, clinical evaluation and monitoring of cancer immunotherapies. This Cancer Immunotherapy Resource Document, prepared by the Society for Immunotherapy of Cancer (SITC, formerly the International Society for Biological Therapy of Cancer, iSBTc), provides key references and online resources relevant to the discovery, evaluation and clinical application of immune biomarkers. These key resources were identified by experts in the field who are actively pursuing research in biomarker identification and validation. This organized collection of the most useful references, online resources and tools serves as a compass to guide discovery of biomarkers essential to advancing novel cancer immunotherapies.

AB - Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are durable, dramatically extending survival. Extensive research efforts are being made to identify and validate biomarkers that can help identify subsets of cancer patients that will benefit most from these novel immunotherapies. In addition to the clear advantage of such predictive biomarkers, immune biomarkers are playing an important role in the development, clinical evaluation and monitoring of cancer immunotherapies. This Cancer Immunotherapy Resource Document, prepared by the Society for Immunotherapy of Cancer (SITC, formerly the International Society for Biological Therapy of Cancer, iSBTc), provides key references and online resources relevant to the discovery, evaluation and clinical application of immune biomarkers. These key resources were identified by experts in the field who are actively pursuing research in biomarker identification and validation. This organized collection of the most useful references, online resources and tools serves as a compass to guide discovery of biomarkers essential to advancing novel cancer immunotherapies.

UR - http://www.scopus.com/inward/record.url?scp=80052850127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052850127&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-9-155

DO - 10.1186/1479-5876-9-155

M3 - Review article

VL - 9

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 155

ER -